UY33166A - Nuevos derivados de tipo pirrolopiridina benzoico - Google Patents

Nuevos derivados de tipo pirrolopiridina benzoico

Info

Publication number
UY33166A
UY33166A UY0001033166A UY33166A UY33166A UY 33166 A UY33166 A UY 33166A UY 0001033166 A UY0001033166 A UY 0001033166A UY 33166 A UY33166 A UY 33166A UY 33166 A UY33166 A UY 33166A
Authority
UY
Uruguay
Prior art keywords
pirrolopiridine
type derivatives
new benzoic
benzoic
new
Prior art date
Application number
UY0001033166A
Other languages
English (en)
Inventor
Jerome Amaudrut
Boubia Benaissa
Guillier Fabrice
Olivia Poupardin-Olivier
Original Assignee
Fournier Lab Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fournier Lab Sa filed Critical Fournier Lab Sa
Publication of UY33166A publication Critical patent/UY33166A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

La presente invención se refiere a compuestos de fórmula: (I) en la cual A, Cy, R1, R2, R3, R4, R5, R6, R7 y R8 son tal como se han definido en la descripción.Los compuestos de la invención son moduladores de los receptores nucleares NURR-1.
UY0001033166A 2010-01-08 2011-01-07 Nuevos derivados de tipo pirrolopiridina benzoico UY33166A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR1050113A FR2955110A1 (fr) 2010-01-08 2010-01-08 Nouveaux derives de type pyrrolopyridine benzoique

Publications (1)

Publication Number Publication Date
UY33166A true UY33166A (es) 2011-08-31

Family

ID=42124595

Family Applications (1)

Application Number Title Priority Date Filing Date
UY0001033166A UY33166A (es) 2010-01-08 2011-01-07 Nuevos derivados de tipo pirrolopiridina benzoico

Country Status (22)

Country Link
US (1) US8546385B2 (es)
EP (1) EP2521727B1 (es)
JP (1) JP2013516448A (es)
KR (1) KR20120123042A (es)
CN (1) CN102753552A (es)
AR (1) AR079842A1 (es)
AU (1) AU2011204518A1 (es)
BR (1) BR112012016844A2 (es)
CA (1) CA2785876A1 (es)
DK (1) DK2521727T3 (es)
EA (1) EA201290601A1 (es)
ES (1) ES2478191T3 (es)
FR (1) FR2955110A1 (es)
HK (1) HK1178893A1 (es)
MX (1) MX2012007968A (es)
PL (1) PL2521727T3 (es)
PT (1) PT2521727E (es)
SA (1) SA111320080B1 (es)
TW (1) TWI473806B (es)
UY (1) UY33166A (es)
WO (1) WO2011083278A1 (es)
ZA (1) ZA201204863B (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102347368B1 (ko) 2020-11-03 2022-01-07 (주)케이메디켐 신규한 아자인돌 유도체, 이의 제조방법 및 이를 포함하는 인지기능 개선용 조성물

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU726637B2 (en) 1996-12-13 2000-11-16 Aventis Pharmaceuticals Inc. Sulfonic acid or sulfonylamino N-(heteroaralkyl)-azaheterocyclylamide compounds
DE69942801D1 (de) * 1998-05-26 2010-11-11 Chugai Pharmaceutical Co Ltd Heterozyklische indolderivate und mono- oder diazaindol-derivate
GB0119911D0 (en) 2001-08-15 2001-10-10 Novartis Ag Organic Compounds
GB0303503D0 (en) * 2003-02-14 2003-03-19 Novartis Ag Organic compounds
AU2004259738B2 (en) 2003-07-17 2011-11-17 Plexxikon, Inc. PPAR active compounds
WO2005047268A2 (en) 2003-11-10 2005-05-26 X-Ceptor Therapeutics, Inc. Substituted pyrimidine compositions and methods of use
FR2890072A1 (fr) * 2005-09-01 2007-03-02 Fournier S A Sa Lab Nouveaux composesde pyrrolopyridine
FR2903105A1 (fr) 2006-07-03 2008-01-04 Sanofi Aventis Sa Derives de 2-benzoyl-imidazopyridines, leur preparation et leur application en therapeutique
FR2903107B1 (fr) 2006-07-03 2008-08-22 Sanofi Aventis Sa Derives d'imidazopyridine-2-carboxamides, leur preparation et leur application en therapeutique
FR2903106B1 (fr) 2006-07-03 2010-07-30 Sanofi Aventis Utilisations de 2-benzoyl-imidazopyridines en therapeutique
WO2008101247A2 (en) 2007-02-16 2008-08-21 Memory Pharmaceuticals Corporation 6 ' substituted indole and indazole derivatives having 5-ht6 receptor affinity
US20100022581A1 (en) 2008-07-02 2010-01-28 Memory Pharmaceuticals Corporation Pyrrolidine-substituted azaindole compounds having 5-ht6 receptor affinity

Also Published As

Publication number Publication date
AU2011204518A1 (en) 2012-07-26
CA2785876A1 (fr) 2011-07-14
EA201290601A1 (ru) 2012-12-28
PT2521727E (pt) 2014-06-25
JP2013516448A (ja) 2013-05-13
FR2955110A1 (fr) 2011-07-15
DK2521727T3 (da) 2014-06-16
PL2521727T3 (pl) 2014-08-29
US8546385B2 (en) 2013-10-01
CN102753552A (zh) 2012-10-24
SA111320080B1 (ar) 2014-06-23
KR20120123042A (ko) 2012-11-07
WO2011083278A1 (fr) 2011-07-14
BR112012016844A2 (pt) 2018-05-08
TW201144307A (en) 2011-12-16
ES2478191T3 (es) 2014-07-18
ZA201204863B (en) 2013-09-25
EP2521727A1 (fr) 2012-11-14
MX2012007968A (es) 2012-08-03
AR079842A1 (es) 2012-02-22
HK1178893A1 (en) 2013-09-19
US20120302560A1 (en) 2012-11-29
EP2521727B1 (fr) 2014-03-19
TWI473806B (zh) 2015-02-21

Similar Documents

Publication Publication Date Title
ECSP14013245A (es) Nuevos derivados dihidroquinolina-2-ona
ZA201308567B (en) Laundry care compositions containing dyes
ECSP12012292A (es) Ciertas amino-piridazinas, composicioines de las mismas y métodos de uso de los mismos
NI201400081A (es) Nuevos derivados de indolizina , su procedimiento de preparación y las composiciones farmacéuticas que los contienen.
SV2011003800A (es) Derivados de piridino-piridinonas, su preparacion y su aplicacion en terapeutica
UY33541A (es) N-((6-amino-piridin-3-il)-metil)-heteroaril-carboxamidas
ECSP12012293A (es) Ciertas amino-pirimidinas, composicioines de las mismas y métodos para el uso de los mismos
DOP2013000307A (es) Antagonistas de trpv4
SV2014004770A (es) Nuevos derivados de pirrol, su procedimiento de preparación y los composiciones farmacéuticas que los contienen
DK2419096T3 (da) Stabilisering af radiofarmaceutiske sammensætninger under anvendelse af ascorbinsyre
DK2616064T3 (da) Ketorolacformuleringer klar til anvendelse
ECSP14013327A (es) Compuestos con actividad nematicida
BR112013004852A2 (pt) turbina do tipo de reação
BR112013023166A2 (pt) geração de microbiocida dentro de um pacote utilizando composição de gás controlada
CR20150171A (es) Benzamidas
EA201590951A1 (ru) Дигидропиразольные модуляторы gpr40
CR20120542A (es) HETEROARIL-CICLOHEXIL-TETRAAZABENZO [e] AZULENOS
MX2013012211A (es) Derivados biciclicos substituidos de metil amina como moduladores de receptores de esfingosina-1-fosfato.
EA201590949A1 (ru) Дигидропиразольные модуляторы gpr40
EA201491195A1 (ru) Способ получения композиции, содержащей галактоолигосахариды
AR093710A1 (es) Mezclas de caucho que contienen alquilesteres de cadena corta de glicerina
CR20120033A (es) Derivados de 5-fluoro-2-oxopirimidina-1-(2h) carboxilato.
PE20151145A1 (es) Piridopirazinas sustituidas como inhibidores de syk
FR2958537B1 (fr) Composition dentaire
TR201903918T4 (tr) Bir dağıtım ajanı içeren bileşimler ve bunların hazırlanması.

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20191121